Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)±folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

This publication has 28 references indexed in Scilit:

• Oxaliplatin: A review of preclinical and clinical studies
  Annals of Oncology, 1998
• Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.
  Journal of Clinical Oncology, 1998
• Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
  European Journal Of Cancer, 1997
• Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
  Annals of Oncology, 1996
• High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II study
  European Journal Of Cancer, 1995
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• Cancer statistics, 1992
  CA: A Cancer Journal for Clinicians, 1992
• A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin
  Investigational New Drugs, 1991
• Low-Dose Continuous Infusion 5-Fluorouracil and Cisplatin
  American Journal of Clinical Oncology, 1989
• Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma
  Cancer Chemotherapy and Pharmacology, 1989